Abstract
In the mouse, Bruton's tyrosine kinase (Btk) is essential for efficient developmental progression of CD43(+)CD2(-) large cycling into CD43(-)CD2(+) small resting pre-B cells in the bone marrow and of IgM(high) transitional type 2 B cells into IgM(low) mature B cells in the spleen. In this study, we show that the impaired induction of cell surface changes in Btk-deficient pre-B cells was still noticeable in kappa(+) immature B cells, but was largely corrected in lambda(+) immature B cells. As A gene rearrangements are programmed to follow K rearrangements and A expression is associated with receptor editing, we hypothesized that the transit time through the pre-B cell compartment or receptor editing may affect the extent of the cellular maturation defects in Btk-deficient B cells. To address this issue, we used 3-83mudelta transgenic mice, which prematurely express a complete B cell receptor and therefore manifest accelerated B cell development. In Btk-deficient 3-83mudelta mice, the IgM(+) B cells in the bone marrow exhibited a very immature phenotype (pre-BCR(+)CD43(+)CD2(-)) and were arrested at the transitional type I B cell stage upon arrival in the spleen. However, these cellular maturation defects were largely restored when Btk-deficient 3-83mudelta B cells were on a centrally deleting background and therefore targeted for receptor editing. Providing an extended time window for developing B cells by enforced expression of the antiapoptotic gene Bcl-2 did not alter the Btk dependence of their cellular maturation. We conclude that premature B cell receptor expression amplifies the cellular maturation defects in Btk-deficient B cells, while extensive receptor editing reduces these defects.
Original language | English |
---|---|
Pages (from-to) | 1371-1379 |
Number of pages | 9 |
Journal | Journal of Immunology |
Volume | 172 |
Issue number | 3 |
Publication status | Published - 1 Feb 2004 |
Externally published | Yes |
Keywords
- ADAPTER PROTEIN SLP-65
- BONE-MARROW
- LIGHT-CHAIN
- LYMPHOCYTE DEVELOPMENT
- ALLELIC EXCLUSION
- TUMOR-SUPPRESSOR
- MICE
- SELECTION
- ANTIBODY
- LAMBDA